🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the producers of acetaminophen, alleging the corporations withheld alleged dangers that the pain reliever presented to children's cognitive development.

The court filing arrives four weeks after President Donald Trump advocated an unverified association between using Tylenol - alternatively called paracetamol - throughout gestation and autism in offspring.

The attorney general is filing suit against the pharmaceutical giant, which previously sold the medication, the sole analgesic approved for expectant mothers, and Kenvue, which presently makes it.

In a official comment, he said they "deceived the public by making money from pain and promoting medication without regard for the risks."

The manufacturer states there is insufficient reliable data connecting Tylenol to autism spectrum disorder.

"These corporations misled for generations, knowingly endangering numerous people to line their pockets," Paxton, from the Republican party, stated.

The company said in a statement that it was "seriously troubled by the perpetuation of misinformation on the security of paracetamol and the potential impact that could have on the well-being of American women and children."

On its website, the company also said it had "regularly reviewed the pertinent research and there is insufficient valid information that indicates a established connection between taking paracetamol and autism spectrum disorder."

Organizations acting on behalf of doctors and health professionals agree.

ACOG has stated acetaminophen - the primary component in Tylenol - is among limited choices for women during pregnancy to address pain and elevated temperature, which can pose significant medical dangers if left untreated.

"In multiple decades of research on the use of paracetamol in gestation, zero credible investigations has conclusively proven that the usage of acetaminophen in any trimester of pregnancy leads to brain development issues in offspring," the organization commented.

The lawsuit mentions recent announcements from the former administration in asserting the medication is reportedly hazardous.

Last month, Trump caused concern from medical authorities when he advised women during pregnancy to "resist strongly" not to consume acetaminophen when ill.

The US Food and Drug Administration then released a statement that physicians should think about restricting the consumption of Tylenol, while also stating that "a direct connection" between the drug and autism spectrum disorder in children has not been proven.

The Health Department head Kennedy, who supervises the Food and Drug Administration, had vowed in April to undertake "extensive scientific investigation" that would establish the source of autism spectrum disorder in a matter of months.

But specialists cautioned that identifying a sole reason of autism spectrum disorder - thought by researchers to be the result of a intricate combination of genetic and environmental factors - would be difficult.

Autism spectrum disorder is a form of permanent neurological difference and disability that impacts how persons perceive and relate to the world, and is identified using medical professional evaluations.

In his lawsuit, Paxton - a Trump ally who is campaigning for US Senate - alleges Kenvue and Johnson & Johnson "willfully ignored and tried to quiet the science" around acetaminophen and autism spectrum disorder.

The lawsuit aims to force the companies "remove any commercial messaging" that asserts Tylenol is safe for expectant mothers.

The Texas lawsuit parallels the grievances of a assembly of guardians of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the producers of Tylenol in 2022.

A federal judge dismissed the lawsuit, declaring investigations from the parents' expert witnesses was not conclusive.